Articles Archives - Onco'Zine

Lung Cancer Among the Most Likely Conditions to Harm Patients who...

Peter Hofland, Ph.D - July 12, 2019

The Signing the National Cancer Act. President Richard Nixon signs the National Cancer Act on December 23, 1971. This is a formal setting with a row of senators visible and some other officials and dignitaries. Courtesy: National Cancer Institute, an agency part of the National Institutes of Health (ID 1935) / Linda Bartlett

Combination Therapy, Combating Cancer from Multiple Flanks

Isaac Israel - July 9, 2019

Three Recommendations to Better Understand HIPAA Compliance

Carol Amick - April 8, 2019

Diet and Cancer: What?s the Connection?

Mark Lowdell - February 20, 2019

After the Cancer Diagnosis: Six Steps for Moving from Fear...

Julie Benezet - February 17, 2019

Dawn of A New Era: Antibody-drug Conjugates in the Treatment...

Peter Hofland, Ph.D - August 29, 2018

Why Academia Wasn’t Ready to Build Big Data Systems – A...

Eric T. Rosenthal - April 10, 2018

New Hybrid Cancer Center Model Helps Meet the Demand for Better...

Peter Hofland, Ph.D - November 27, 2017

Faculty presentations during Oncology (ASCO) Annual Meeting

Online Technology Designed to Help Patients Play an Active Role in...

Peter Hofland, Ph.D - June 9, 2017

Supplemental Biologics License Application for Obinutuzumab Approved for Previously Untreated Chronic...

Editorial Team - December 24, 2014

12 3 Page 1 of 3

LATEST NEWS

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Danielle Garcia - June 16, 2020

Press Releases | Cancer

Reaction from Cory Watson Attorneys: $10 Billion Settlement Reached in... July 1, 2020
Bayer, the maker of weed killer Roundup, will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its product causes cancer. Monsanto lost its first three Roundup trials...(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/reaction_from_cory_watson_attorneys_10_billion_settlement_reached_in_roundup_weed_killer_cancer_litigation/prweb17229746.htm
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches... July 1, 2020
Internal research programs to focus on building combination immunotherapies for brain cancer(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/silicon_beach_based_nonprofit_startup_cure_glioblastoma_launches_laboratory_operations_and_appoints_drs_john_boockvar_and_lisa_haile_as_senior_fellows/prweb17226957.htm
Lumeda Announces Formation of its Scientific Advisory Board July 1, 2020
Prominent medical and scientific experts to help company advance development of PDT products.(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/lumeda_announces_formation_of_its_scientific_advisory_board/prweb17222019.htm
Latest Data on IO Combinations Will Be Announced at the IO... June 30, 2020
IO Combinations 360°, organized by the Conference Forum, a combination-specific program, reports on the latest data and advancements to expedite more accurate therapies for patients faster taking...(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/latest_data_on_io_combinations_will_be_announced_at_the_io_combinations_360_conference_october_1_2_2020/prweb17225687.htm
Flagship Biosciences Launches New Clinical Diagnostics Service June 30, 2020
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient Care(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/flagship_biosciences_launches_new_clinical_diagnostics_service/prweb17223687.htm
AltruBio Inc. presented AbGn-107 Phase 1a chemo-refractory GI cancer... June 29, 2020
AltruBio Inc. http://www.altrubio.com, a clinical stage biotech company, has announced the presentation of AbGn-107 at the 2020 ASCO GI Cancer...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/altrubio_inc_presented_abgn_107_phase_1a_chemo_refractory_gi_cancer_results_at_asco_gi_2020/prweb17222550.htm
Dimensional Insight Announces Registration Sponsorship of St. Jude... June 29, 2020
Event benefits kids with childhood cancer, other life-threatening diseases at St. Jude Children’s Research Hospital(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/dimensional_insight_announces_registration_sponsorship_of_st_jude_walk_run_boston/prweb17222315.htm
iRECIST Criteria: An Operational Approach in Oncology Clinical Trials,... June 29, 2020
In this free webinar, the featured speakers will discuss concepts of establishing iUPD and iCPD by category and data scenarios across imaging time point visits. Attendees will learn about image case...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/irecist_criteria_an_operational_approach_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17222231.htm
The Lymphoma Research Foundation Hosts Inaugural Swirl: America, An At... June 29, 2020
LRF Spokesperson and Acclaimed Journalist Lisa Guerrero Kicks Off Nationwide Cheeseboard Challenge to Drive Lymphoma Awareness(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/the_lymphoma_research_foundation_hosts_inaugural_swirl_america_an_at_home_tasting_virtual_fundraiser/prweb17222149.htm
Managing Abnormal Results on Cervical Cancer Screening: ASCCP Issues... June 28, 2020
Published in Journal of Lower Genital Tract Disease, New Recommendations Focus on More Personalized Risk Assessment and Management(PRWeb June 28, 2020)Read the full story at https://www.prweb.com/releases/managing_abnormal_results_on_cervical_cancer_screening_asccp_issues_updated_guidelines/prweb17219257.htm
New US Patent Protects Key Element of First-in-Class Prodrug Candidate... June 26, 2020
Tumor-targeting and tumor-penetrating peptide enables EnduRx Pharmaceuticals novel prodrug for triple-negative breast cancer(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/new_us_patent_protects_key_element_of_first_in_class_prodrug_candidate_for_triple_negative_breast_cancer/prweb17214155.htm
PathAI and Bristol Myers Squibb find positive association of digital... June 26, 2020
Digital analysis shows higher sensitivity for PD-L1 expression and accurate detection of low-level PD-L1 expression in patients compared to manual reading(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/pathai_and_bristol_myers_squibb_find_positive_association_of_digital_pd_l1_expression_with_outcomes_in_nivolumab_treated_patients_in_an_exploratory_analysis/prweb17220807.htm
Lumeda Enters License Agreement with Roswell Park Comprehensive Cancer... June 25, 2020
Company secures exclusive rights for intraoperative photodynamic therapy in the treatment of non-small cell lung cancer(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/lumeda_enters_license_agreement_with_roswell_park_comprehensive_cancer_center/prweb17218726.htm
Texas Breast Cancer Survivor Launches Experiential Website to Help... June 25, 2020
It would take Stage 3 Breast Cancer in 2011 for Stephanie Johnson to consider cannabis. Now, having survived longer than anticipated, she hopes to help others feel more comfortable, too.(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/texas_breast_cancer_survivor_launches_experiential_website_to_help_others_searching_for_quality_hemp_cbd_information/prweb17211906.htm

Articles

Detect Cancer Early: Liquid Biopsy Based ctDNA Methylation as a Promising Diagnostic Approach

Smoking Cessation as an Integral Part of the Treatment of Patients with Cancer

Drug-loaded Nanoparticles Bound to Circulating Red Blood Cells Inhibit Lung Cancer Metastasis

Broadening the Applicability of CAR-T Immunotherapy to Treat the Untreatable

Nobel Prize in Physiology or Medicine 2019: How do Cells Sense and Adapt to Availability of Oxygen